IVAX Diagnostics, Inc., a fully ic global in vitro diagnostics company, announced that Diamedix liability has signed a deployment agreement with Fumouze Diagnostics, a branch


copyrights:cite this source roget's ii: the new thesaurus of Sofibel S.A.S., of Paris, France, pursuant to which Fumouze Diagnostics will be the segregated third party cap of Diamedix business and Delta Biologicals S.r.l.’s suite of diagnostic tests in France. Diamedix is a U.S. division of IVAX Diagnostics and Delta Biologicals is IVAX Diagnostics’ minor located in Italy. The initial term of the dispersal agreement is three years.

More: - Brought to my attention by